Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20265 Citations
Adipotide (FTPP) destroyed 38% of total body fat in primate studies by cutting off blood supply to fat tissue. Clinical development was permanently halted after kidney toxicity appeared at sub-therapeutic doses. No safe human dose has been identified, and all clinical development ended permanently in 2019.
0.5mcg · Daily
Summary: Add 2mL BAC water to your 5mg vial. Draw to < 0.1 units on a U-100 syringe for a 0.5mcg dose. This vial will last 10000 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 0.5mg | Daily |
| Moderate | 1mg | Daily |
| Aggressive | 2mg | Daily |
Start with the math. A 5 mg vial reconstituted with 2 mL bacteriostatic water gives you 2.5 mg/mL. At 0.5 mg per dose, that's 0.2 mL per injection, or 20 units on an insulin syringe. One 5 mg vial covers 10 days at that dose. A full 28-day cycle at 0.5 mg/day needs roughly three 5 mg vials (14 mg total). Store lyophilized powder at -20C. This compound degrades faster than simpler peptides at warmer temperatures. Once reconstituted, refrigerate at 2 to 8C and use within 14 days. The thing most people miss: the effective primate dose (0.43 mg/kg/day) translates to about 30 mg/day for a 70 kg human. Community doses of 0.5 to 1 mg/day are 30 to 60 times lower. You're almost certainly below the therapeutic threshold, and that's intentional. You'll hit kidney toxicity before you hit efficacy if you try to close that gap. Get a full renal panel before you start. Creatinine, BUN, urinalysis, GFR. Repeat at day 7 and day 14. If creatinine moves more than 20% from baseline, you're done. Stop NSAIDs at least a week before starting. Drink 3-plus liters of water daily; your kidneys concentrate this peptide during excretion.
Dosing based on Dose extrapolated from primate study (PMID 21734721) using allometric scaling — 6 published references.View all sources →
Cross-check your Adipotide (FTPP) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Adipotide (FTPP) destroyed 38% of total body fat in primate studies by cutting off blood supply to fat tissue. Clinical development was permanently halted after kidney toxicity appeared at sub-therapeutic doses. No safe human dose has been identified, and all clinical development ended permanently in 2019.